Literature DB >> 13057393

Epidemiology of penicillin- and aureomycin-resistant staphylococci in a hospital population.

M H LEPPER, H F DOWLING, G G JACKSON, M M HIRSCH.   

Abstract

Entities:  

Keywords:  AUREOMYCIN/resistance and sensitivity; MICROCOCCUS PYOGENES/resistance and sensitivity; PENICILLIN/resistance and sensitivity

Mesh：

Substances：

Year:  1953        PMID： 13057393     DOI： 10.1001/archinte.1953.00240190052003

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  8 in total

1.  Acute pseudomembranous enterocolitis in the postoperative patient.

Authors:  R E WEISMANN; E B TWITCHELL
Journal:  Ann Surg       Date:  1956-07       Impact factor: 12.969

2.  Management of the pulmonary complications of antibiotic therapy.

Authors:  A L BARACH
Journal:  Bull N Y Acad Med       Date:  1954-07

Review 3.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Yearly incidence of penicillin-resistant staphylococci in man since 1942.

Authors:  E MUNCH-PETERSEN; C BOUNDY
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

5.  Staphylococcal Nasal Carriage in the Family.

Authors:  C R Kay
Journal:  J Coll Gen Pract       Date:  1963-02

6.  Studies on the Origin of Drug-Resistant Staphylococci in a Mental Hospital.

Authors:  V Knight; A White; T Hemmerly; M P Martin
Journal:  Trans Am Clin Climatol Assoc       Date:  1959

7.  Colonization of newly arrived house staff by virulent staphylococcal phage types endemic to a hospital environment.

Authors:  W R Ballou; A S Cross; D Y Williams; J Keiser; C H Zierdt
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

Review 8.  Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.

Authors:  Brad Spellberg; George H Talbot; Helen W Boucher; John S Bradley; David Gilbert; W Michael Scheld; John Edwards; John G Bartlett
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.